The Role of Education and Social Factors in Rheumatic and Musculoskeletal Diseases

Emerging research emphasizes the critical role of social determinants like income and education in shaping outcomes for patients with rheumatic and musculoskeletal diseases. Findings from the EULAR 2025 congress reveal how these factors influence disease progression and mortality, highlighting the need for targeted interventions to promote health equity.
Recent research highlights the significant influence of social determinants of health (SDH), such as socioeconomic status and educational background, on outcomes in chronic rheumatic and musculoskeletal diseases (RMDs). These factors are increasingly recognized as critical contributors to disease progression and patient well-being. Studies presented at the EULAR 2025 congress in Barcelona shed light on how SDH impact conditions like systemic lupus erythematosus (SLE) and inflammatory arthritis.
Systemic lupus erythematosus (SLE), a complex autoimmune disease characterized by clinical heterogeneity, often results in severe morbidity and increased mortality. Despite the known disparities linked to SDH, limited research has been conducted in unselected European populations. A Swedish population-based cohort of 2,434 newly diagnosed SLE patients revealed that lower income and limited education significantly increased the risk of organ damage and mortality. Specifically, individuals with an annual income below the median and less than nine years of education faced a 30–40% higher chance of organ damage compared to their counterparts.
Marital status also played a role, with divorced or widowed individuals showing a heightened risk of organ damage. Additionally, a history of sick leave or disability was associated with more than a 40% increased risk of organ damage. When examining mortality, those in the lowest income and education brackets faced more than double the risk, with single, separated, or widowed individuals at greater mortality risk. Interestingly, being born outside Sweden did not influence these outcomes.
Researchers emphasized that understanding these social determinants enables targeted interventions, such as improving healthcare access, health literacy, and community support networks, which could mitigate adverse outcomes.
Further investigation into inflammatory arthritis by King’s College London highlighted the impact of health literacy on disease management and work productivity. Participants with limited health literacy reported higher disease activity, increased anxiety and depression, and more severe symptoms. Limited health literacy was also linked to higher corticosteroid use and greater work impairment, including absenteeism and presenteeism.
These findings underscore the importance of addressing social and educational barriers in managing RMDs. Enhancing health literacy and addressing social disparities could lead to better clinical outcomes and improved quality of life for patients.
Overall, these studies advocate for integrating social determinants into healthcare strategies for rheumatic diseases, ultimately aiming to reduce health inequalities and optimize patient care.
Source: https://medicalxpress.com/news/2025-06-impact-social-factors-rheumatic-musculoskeletal.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Comprehensive Approaches to Cholesterol Management Beyond Medication Adherence
A systematic review highlights the importance of multi-component strategies for sustained cholesterol management, emphasizing behavioral, educational, and systemic interventions to improve medication adherence and long-term health outcomes.
New Research Reveals Intestinal Surface Cells Use Pulling Forces to Remove Weak Neighbors
New research uncovers that intestinal surface cells pull on each other to identify and remove weak or malfunctioning cells, ensuring intestinal integrity and health.
AI-Driven Design Boosts Efficacy of Bi-specific CAR T Cells in Cancer Therapy
A pioneering computational method developed by St. Jude researchers significantly improves the design and efficacy of bi-specific CAR T cells, offering new hope for tackling heterogeneous and resistant tumors. This approach accelerates development, enhances tumor targeting, and could transform cancer immunotherapy strategies.



